Landmark Bio translates groundbreaking research into life-changing medicines by providing comprehensive development, manufacturing, and regulatory services to early-stage life science innovators. Founded in 2021 and based in Watertown, Massachusetts, Landmark Bio unites industry leaders, academic institutions, and research hospitals to foster innovation in the life sciences arena. As a public benefit company, its mission is to advance emerging technologies that exhibit therapeutic potential and enhance human health. Landmark Bio emphasizes a collaborative environment and seeks to bridge the gap between research and clinical application, making it an exciting opportunity for professionals looking to contribute to cutting-edge developments in healthcare.